Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study

被引：0

作者：

Vieito Villar, M. ^{[1
]}

Sepulveda Sanchez, J. M. ^{[2
]}

Moreno Garcia, V. ^{[3
]}

Lombardi, G. ^{[4
]}

Stradella, A. ^{[5
]}

Dahlrot, R. H. ^{[6
]}

Haslund, C. A. ^{[7
,8
]}

Geurts, M. ^{[9
]}

Pineda, E. ^{[10
]}

Brandal, P. ^{[11
]}

De Vos, F. Y. F. L. ^{[12
]}

Vaz Salgado, M. A. ^{[13
]}

Martinez Garcia, M. ^{[14
]}

Macchini, M. ^{[15
]}

Amoroso, B. ^{[16
]}

Sanchez, T. ^{[16
]}

Hanna, B. ^{[17
]}

Li, X. ^{[17
]}

Nikolova, Z. ^{[16
]}

Simonelli, M. ^{[18
,19
]}

机构：

[1] Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

[2] Hosp Univ 12 Octubre, Med Oncol, Madrid, Spain

[3] Hosp Univ Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain

[4] IOV IRCCS, Ist Oncol Veneto, Dept Oncol, Oncol 1, Padua, Italy

[5] Inst Catala Oncol, Dept Med Oncol, Barcelona, Spain

[6] Odense Univ Hosp, Dept Oncol, Odense, Denmark

[7] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark

[8] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark

[9] Erasmus MC Canc Inst, Dept Neurol, Rotterdam, Netherlands

[10] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[11] Oslo Univ Hosp, Dept Oncol, Oslo, Norway

[12] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands

[13] Hosp Univ Ramon y Cajal, Dept Med Oncol, Madrid, Spain

[14] Hosp del Mar, Dept Med Oncol, Barcelona, Spain

[15] IRCCS San Raffaele Sci Inst, Med Oncol, Milan, Italy

[16] Ctr Innovat & Translat Res Europe, Early Clin Dev, Seville, Spain

[17] Bristol Myers Squibb, Clin Pharmacol, Princeton, NJ USA

[18] Humanitas Univ, IRCCS Humanitas Res Hosp, Dept Hematol & Oncol, Milan, Italy

[19] Humanitas Univ, Dept Biomed Sci, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1694

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

500O

引用

页码：S392 / S392

页数：1